With 1,053 lives lost to alcohol-related crashes in Texas in 2024, Houston-based Armstrong Lee & Baker LLP is attempting to curb holiday tragedy by launching a reimbursement program for rideshare services. The initiative covers cab, Uber, or Lyft fares for Houston residents to ensure they arrive home safely this Independence Day.
With backing from Skeleton Key and Merck Global Health Innovation Fund, Montreal-based DropGenie has closed a Seed+ financing round to move its gene editing platform toward full commercial launch. The startup aims to transform drug discovery by miniaturizing workflows to allow direct experimentation on primary patient cells.
Dustin J. Semach, the current President and CEO of Sealed Air Corporation, joined the Polaris Inc. Board of Directors effective June 19, 2026. His appointment brings a background in global business transformation and finance to the Minnesota-based powersports manufacturer as it navigates its next phase of strategic growth.
Jersey City-based insurance holding company Novel Financial Holdings has secured a strategic investment from private equity firm Flexpoint Ford. The capital injection, drawn from Flexpoint's Asset Opportunity Fund III and Insurance Opportunity Fund I, aims to accelerate Novel’s expansion as a diversified underwriting and services platform.
Freight brokerage software startup Chain has unveiled its Autopilot Booking Agent, an AI-driven tool designed to manage carrier outreach, rate negotiations, and compliance vetting. By integrating directly into existing communication channels, the system aims to handle routine booking tasks while escalating complex decisions to human representatives.
Fans of the web-slinging hero can step into Peter Parker’s world this summer as Little Caesars teams up with Sony Pictures for the release of Spider-Man: Brand New Day. The collaboration centers on a custom menu item and an immersive apartment replica experience arriving in Brooklyn later this month.
Brenig Therapeutics is turning to artificial intelligence to bypass a long-standing hurdle in neurology: the difficulty of designing drugs that are both highly selective and capable of crossing the blood–brain barrier to treat neuroinflammatory conditions like Parkinson’s disease.
Investors who held FirstEnergy Corp. common stock between 2017 and 2020 are now eligible to file claims for a portion of a $100 million penalty fund. The Securities and Exchange Commission established the distribution following findings that the utility company misled shareholders during a multi-year political corruption scheme.
Ningbo-based TrueLab Biopharmaceutical has signed an exclusive global licensing agreement with the newly launched Bionyra Pharma for two next-generation antibody candidates. The deal, valued at up to $985 million, grants Bionyra rights to develop and commercialize the TL-001 and TL-003 programs outside of Greater China.
Reducing the risk of death by 51%, the European Commission has greenlit a new targeted therapy regimen for adults with BRAFV600E-mutant metastatic colorectal cancer. The approval positions the combination of BRAFTOVI, cetuximab, and FOLFOX as the first and only targeted therapy available for these patients in a first-line setting.
Professional service firms in the U.S. are facing a combined $143 billion in revenue at risk as corporate clients prepare to move business away from providers failing to integrate artificial intelligence. A new report suggests that while AI adoption is widespread, a significant execution gap is driving talent turnover and security risks.
Mobileye is pivoting to a vertically integrated robotaxi business, naming Innoviz Technologies as its core LiDAR provider. The initiative aims to launch in a major U.S. city by 2027, utilizing a fleet that relies on the InnovizTwo sensor platform to navigate complex urban environments for autonomous ride-hailing.
At the 2026 NFPA Conference & Expo in Las Vegas, Firetrace International and Standard Fluids Corporation announced a strategic partnership to integrate specialized fire suppression hardware with high-performance clean agent fluids, aiming to secure critical infrastructure across the industrial, clean energy, and data center sectors.
The search landscape has fractured, shifting from simple engine rankings to a complex web of AI assistants and social platforms. On June 25, 2026, Spinutech experts Kip Russell and Taylor Fisher will address this volatility at the C-Vision Data AI & CMO Think Tank in Chicago, offering a new framework for brand discoverability.
With demand for GLP-1 medications surging, CVS Health is rolling out a multi-pronged strategy to reduce costs and improve adherence. The initiative includes a $50 monthly copay for eligible Medicare patients, $49 virtual weight management consultations, and targeted in-store resources to help users manage common side effects.
The New Hampshire Department of Education has tapped Critical Response Group to deploy GIS-enabled, field-validated mapping across every public school in the state. The multi-year contract aims to synchronize incident data for administrators, police, and EMS, ensuring all responders operate from a single, high-fidelity visual reference during crises.
Ningbo-based TrueLab Biopharmaceutical has signed an exclusive licensing agreement with clinical-stage startup Bionyra Pharma, granting the latter worldwide rights—excluding Greater China—to two advanced antibody therapies. The deal, valued at up to $985 million, includes upfront payments, development milestones, and a minority equity stake for TrueLab.
At Dublin’s LocWorld55, XTM International secured the 2026 Innovator of the Year title during the Process Innovation Challenge. Product Director Sara Basile claimed the award by presenting XTM Go, a gateway designed to automate enterprise translation by prioritizing content analysis over manual system configuration.
For the second consecutive year, Jacksonville-based Consulting Solutions has secured the Platinum Level Healthiest Companies Award from the First Coast Worksite Wellness Council. The designation marks a continued upward trajectory for the technology firm, which earned Gold status in 2024 before claiming the council’s highest tier in 2025.
The Ellison Medical Institute has finalized an exclusive licensing agreement with UniQuest to advance QED-203, a promising small-molecule therapy designed to treat metastatic castration-resistant prostate cancer. The partnership aims to leverage AI-enabled discovery and clinical expertise to bring the treatment into first-in-human trials by early 2027.
Two mentoring pairs from Indiana and the Bay Area have been named the 2026 Bigs and Littles of the Year by Big Brothers Big Sisters of America. The awards, presented in Atlanta on June 18, recognize the transformative power of long-term, consistent relationships in navigating personal adversity and life-changing health challenges.
Two hundred and fifty Bluebikes, the Greater Boston bike-share fleet, have been outfitted with custom artistic wraps to mark America’s 250th anniversary. The initiative, spearheaded by Blue Cross Blue Shield of Massachusetts, combines public art with ride incentives to encourage residents to engage with citywide summer festivities.
On June 11, XTM International secured the 2026 Innovator of the Year – Europe title at the LocWorld Process Innovation Challenge. Product Director Sara Basile accepted the award in Dublin, outperforming 28 other submissions with a pitch centered on automating enterprise translation through intelligent, risk-aware triage.
Williamsburg’s VIBE TWLV is shedding its identity as a traditional retail space to launch SUPERNORMAL, a recurring cultural program. Starting June 27, the 4,270-square-foot facility at 50 Berry Street will host site-responsive collaborations that merge high-end fashion, art, and commerce into a single, evolving installation series.
After four decades in the packaging industry, Roberto Villaquiran is stepping down as CEO of Klöckner Pentaplast. The company has moved quickly to fill the vacancy, appointing board member and industry veteran Michael Zacka to lead the firm on an interim basis effective June 22, 2026.
Amidst intensifying geopolitical friction and a rapid digital evolution, World Finance has unveiled its Summer 2026 edition. The publication centers on the forces currently redefining global markets, ranging from the strategic necessity of petroleum reserves in the Middle East to the maturation of cryptocurrency as a core financial infrastructure.
With lower-extremity injuries in the NBA hitting record highs, Golden State Warriors guard Gary Payton II has signed on as Chief Athletic Ambassador for Valor, the sports medicine division of Vector Science & Therapeutics. The move aims to integrate elite athlete feedback into non-addictive pain management and tissue repair platforms.
Beginning January 1, 2027, Oklahomans purchasing coverage through the ACA Marketplace will gain access to integrated Direct Primary Care services. The collaboration between Tulsa-based CommunityCare and technology firm Mending aims to shift the regional primary care landscape toward a more personal, preventive, and relationship-driven model for families and individuals.
Regulators in China have granted approval for satricabtagene autoleucel, or satri-cel, marking the first time a CAR T-cell therapy has been cleared globally for the treatment of solid tumors. The therapy targets Claudin18.2-positive, HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma in patients who have exhausted standard treatment options.
Dallas-based global investment manager Canyon Partners has closed its latest European collateralized loan obligation at €400 million, pushing the firm's total European platform assets under management past the €2.1 billion mark as it navigates a tightening credit market.
